Zimmer Biomet Holdings (ZBH) Liabilities and Shareholders Equity (2009 - 2026)

Zimmer Biomet Holdings' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $22.7 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 501.48% year-over-year to $22.7 billion; the TTM figure through Mar 2026 stood at $54.0 billion (up 6.36% YoY), while the FY2025 annual figure was $23.1 billion, up 521.41% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $22.7 billion, down from $23.1 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $23.1 billion in Q4 2025, with the low at $3.5 billion in Q4 2022.
• The 5-year median for Liabilities and Shareholders Equity is $21.3 billion (2022), against an average of $16.4 billion.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity slumped 84.96% in 2022, then soared 521.41% in 2025.
• Zimmer Biomet Holdings' Liabilities and Shareholders Equity stood at $3.5 billion in 2022, then jumped by 509.2% to $21.5 billion in 2023, then tumbled by 82.71% to $3.7 billion in 2024, then jumped by 521.41% to $23.1 billion in 2025, then decreased by 1.6% to $22.7 billion in 2026.
• Business Quant data shows ZBH's Liabilities and Shareholders Equity at $22.7 billion in Q1 2026, $23.1 billion in Q4 2025, and $4.1 billion in Q3 2025.